Penumbra, Inc. (NYSE:PEN – Get Free Report)’s stock price hit a new 52-week high during trading on Wednesday following a better than expected earnings announcement. The company traded as high as $304.

Cat 5 (Stryker Neurovascular, Fremont, CA) in four cases, Fargo Max (Balt, Montmorency, France) in three cases, Benchmark (Penumbra, Alameda, CA) in two cases and Vasco Mini (Balt, Montmorency, France ...

Penumbra Inc (NYSE:PEN) reported a strong revenue growth of 12.9% year over year for Q4 2024, reaching $321.3 million, with a 13% growth on a constant currency basis. The US thrombectomy business ...

At this time, I would like to welcome everyone to Penumbra's Fourth Quarter 2024 Conference ... representing underlying year-over-year growth of 12.9% on an adjusted basis and 13% on a constant ...

ALAMEDA, Calif. (AP) — ALAMEDA, Calif. (AP) — Penumbra Inc. (PEN) on Tuesday reported fourth-quarter profit of $33.7 million. On a per-share basis, the Alameda, California-based company said ...

In the reported quarter, Penumbra’s gross profit improved 12.7% year over year to $210.7 million. The gross margin expanded 110 basis points to 66.8% despite a 7.3% rise in the cost of revenues.

However, de Penumbra Inc (PEN) reports a robust 12.9% revenue increase in Q4 2024, driven by US thrombectomy sales, despite facing international revenue declines. The headline numbers for Penumbra ...

is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period. Earnings Per Share (TTM ...